Search

everythinglearnresearchcommunity

for

Search:↓

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

Most patients improved with oral contraceptives, but some needed additional treatment.

Removing both ovaries treated the woman's excess male hormone symptoms.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

Female relatives of PCOS patients have a higher chance of showing PCOS symptoms.

Women with type 1 diabetes often have polycystic ovary syndrome and excess male hormones, which are frequently undiagnosed.

GnRH analogues are effective for diagnosing and treating female androgen excess, offering a non-surgical option.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Many children and teens referred to gender services receive hormone treatments, but more research is needed on their long-term care and outcomes.

The combination therapy reduced hirsutism in women with PCOD and was well-tolerated.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

Hirsutism is too much hair growth in women like the pattern in men, often caused by high male hormones, and can be treated with hormone control and hair removal methods.

Acupuncture may improve reproductive and metabolic functions in PCOS without negative side effects, but more research is needed to confirm its effectiveness.

Polycystic Ovary Syndrome (PCOS) is a hormonal disorder in women that can cause infertility and other health issues, and it may be improved by treatments that increase insulin sensitivity.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.

Removing both ovaries may better treat increased male hormone levels and related symptoms in postmenopausal women when hormone therapy doesn't work.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

Effective hair loss treatment in women requires correct diagnosis and can include medications like minoxidil, antiandrogens, and treatments for underlying conditions like PCOS.

The document concludes that Functional Hypothalamic Amenorrhea should be carefully diagnosed and managed to prevent health complications, using lifestyle changes and specific medications.

The hypothesis suggests that PCOS may start early in life due to genetic and environmental factors, influencing future reproductive and metabolic problems.

Excess androgens may cause PCOS, not just be a symptom.

Finasteride effectively reduces hair growth in women with polycystic ovary syndrome or idiopathic hirsutism.

The document concludes with guidance for doctors on diagnosing and treating hirsutism effectively and safely.

High levels of male hormones in women without tumors are linked to metabolic problems and can be treated with metformin.

The document concludes that sex hormones are crucial for mammalian reproduction, health, and behavior, and require more research for therapeutic use.